Literature DB >> 33236787

α-Asarone, β-asarone, and γ-asarone: Current status of toxicological evaluation.

Thomas Uebel1, Lena Hermes1, Sabrina Haupenthal1, Lena Müller1, Melanie Esselen1.   

Abstract

Asarone isomers are naturally occurring in Acorus calamus Linné, Guatteria gaumeri Greenman, and Aniba hostmanniana Nees. These secondary plant metabolites belong to the class of phenylpropenes (phenylpropanoids or alkenylbenzenes). They are further chemically classified into the propenylic trans- and cis-isomers α-asarone and β-asarone and the allylic γ-asarone. Flavoring, as well as potentially pharmacologically useful properties, enables the application of asarone isomers in fragrances, food, and traditional phytomedicine not only since their isolation in the 1950s. However, efficacy and safety in humans are still not known. Preclinical evidence has not been systematically studied, and several pharmacological effects have been reported for extracts of Acorus calamus and propenylic asarone isomers. Toxicological data are rare and not critically evaluated altogether in the 21st century yet. Therefore, within this review, available toxicological data of asarone isomers were assessed in detail. This assessment revealed that cardiotoxicity, hepatotoxicity, reproductive toxicity, and mutagenicity as well as carcinogenicity were described for propenylic asarone isomers with varying levels of reliability. The toxicodynamic profile of γ-asarone is unknown except for mutagenicity. Based on the estimated daily exposure and reported adverse effects, officials restricted or published recommendations for the use of β-asarone and preparations of Acorus calamus. In contrast, α-asarone and γ-asarone were not directly addressed due to a limited data situation.
© 2020 The Authors. Journal of Applied Toxicology published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Acorus calamus; alkenylbenzene; carcinogenicity; genotoxicity; metabolism; mutagenicity; phenylpropanoid; phenylpropene

Mesh:

Substances:

Year:  2020        PMID: 33236787     DOI: 10.1002/jat.4112

Source DB:  PubMed          Journal:  J Appl Toxicol        ISSN: 0260-437X            Impact factor:   3.446


  4 in total

1.  β-asarone suppresses HCT116 colon cancer cell proliferation and liver metastasis in part by activating the innate immune system.

Authors:  Min Chen; Yu-Wen Zhuang; Cun-En Wu; Hai-Yan Peng; Jun Qian; Jin-Yong Zhou
Journal:  Oncol Lett       Date:  2021-03-31       Impact factor: 2.967

2.  Revealing the Antiepileptic Effect of α-Asaronol on Pentylenetetrazole-Induced Seizure Rats Using NMR-Based Metabolomics.

Authors:  Xue Zhao; Lihong Liang; Ru Xu; Peixuan Cheng; Pu Jia; Yajun Bai; Yajun Zhang; Xinfeng Zhao; Xiaohui Zheng; Chaoni Xiao
Journal:  ACS Omega       Date:  2022-02-09

Review 3.  Molecular Mechanisms and Therapeutic Potential of α- and β-Asarone in the Treatment of Neurological Disorders.

Authors:  Rengasamy Balakrishnan; Duk-Yeon Cho; In-Su Kim; Sang-Ho Seol; Dong-Kug Choi
Journal:  Antioxidants (Basel)       Date:  2022-01-29

4.  α-Asarone Attenuates Osteoclastogenesis and Prevents Against Oestrogen-Deficiency Induced Osteoporosis.

Authors:  Hao Tian; Tao Jiang; Kai Yang; Ruonan Ning; Tianqi Wang; Qi Zhou; Niandong Qian; Ping Huang; Lei Guo; Min Jiang; Xiaobing Xi; Xing Xu; Lianfu Deng
Journal:  Front Pharmacol       Date:  2022-03-18       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.